Stahl, M.* ; Li, Q.* ; Lynch, K.* ; Koletzko, S.* ; Mehta, P.* ; Gragert, L.* ; Norris, J.M.* ; Andrén Aronsson, C.* ; Lindfors, K.* ; Kurppa, K.* ; Ilonen, J* ; Krischer, J.* ; Alkolkar, B.* ; Ziegler, A.-G. ; Toppari, J.* ; Rewers, M.* ; Agardh, D.* ; Hagopian, W.* ; Liu, E.*
Incidence of pediatric celiac disease varies by Region: Celiac disease varies by Region.
Am. J. Gastroenterol. 118, 539-545 (2023)
OBJECTIVES: The Environmental Determinants of Diabetes in the Young (TEDDY) study follows an HLA-risk selected birth cohort for celiac disease (CD) development using a uniform protocol. Children under investigation come from 6 different regions within Europe and the United States. Our aim was to identify regional differences in celiac disease autoimmunity (CDA) and CD cumulative incidence for children born between 2004 and 2010. METHODS: Children (n=6,628) with DQ2.5 and/or DQ8.1 were enrolled prospectively from birth in Georgia, Washington, Colorado, Finland, Germany, and Sweden. Children underwent periodic study screening for tissue transglutaminase antibodies (tTGA) and then CD evaluation per clinical care. Population-specific estimates were calculated by weighting the study-specific cumulative incidence with the population-specific haplogenotype frequencies obtained from large stem cell registries from each site. RESULTS: Individual haplogenotype risks for CDA and CD varied by region and affected the cumulative incidence within that region. The CD incidence by age 10 years was highest in Swedish children at 3%. Within the US, the incidence by age 10 in Colorado was 2.4%. In the HLA, sex, and family history-adjusted model, Colorado children had a 2.5-fold higher risk of CD compared to Washington. Likewise, Swedish children had a 1.4-fold and 1.8-fold higher risk of CD compared to Finland and Germany, respectively. CONCLUSIONS: There is high regional variability in cumulative incidence of CD which suggests differential environmental, genetic, and epigenetic influences even within the United States. The overall high incidence warrants a low threshold for screening and further research on region-specific CD triggers.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Keywords plus
Language
english
Publication Year
2023
Prepublished in Year
2022
HGF-reported in Year
2022
ISSN (print) / ISBN
0002-9270
e-ISSN
1572-0241
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 118,
Issue: 3,
Pages: 539-545
Article Number: ,
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
New York, NY
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30201 - Metabolic Health
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502100-001
Grants
Copyright
Erfassungsdatum
2022-10-18